IKEM repeatedly violated laws and its own rules in the management of its assets
Between the years 2022 and 2024, the Institute for Clinical and Experimental Medicine (abbreviated as IKEM in Czech) repeatedly violated both laws and its own regulations when managing assets and public funds. This was revealed in an audit of the Supreme Audit Office (SAO), which examined 102 cases involving the management of funds totalling CZK 905.3 million.